PostpartumNCT07295015
Digital Maternal Support Tool Implementation
A study testing Smartphone application in people with Postpartum, run by University of Pittsburgh at 1 site in United States.
Trial summary
The goal of this trial is to learn if a smartphone app designed to provide postpartum support is acceptable to new mothers in Pennsylvania. The main questions it aims to answer are: How easy is the app is to use? Does the app meet the needs of new parents? Is using the app associated with better understanding of… Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Postpartum
- What is being tested?
- Smartphone application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Dec 2025to 29 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Recently delivered one or two live births at hospital recruitment site
- 18-45 years of age
- Can participate in English
- Has smartphone access for at least two months (study duration)
Who cannot join
- Did NOT recently deliver one or two live births at hospital recruitment site
- <18 or >45 years of age
- Cannot participate in English
- Does not have smartphone for at least two months (study duration)
Trial locations and contacts
1 site in 1 country.
United States1 site
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, 15213
About this study
Official title: Digital Maternal Support Tool Implementation: Research to Inform a Statewide Postpartum App Implementation Strategy
The goal of this trial is to learn if a smartphone app designed to provide postpartum support is acceptable to new mothers in Pennsylvania. The main questions it aims to answer are:
- How easy is the app is to use?
- Does the app meet the needs of new parents?
- Is using the app associated with better understanding of critical postpartum symptoms?
- Is using the app associated with endorsement of positive parenting statements?
Participants will:
- Use a postpartum support app on their smartphones for 8 weeks
- Answer survey questions about their experience
Read the detailed description
The goal of this clinical trial is to evaluate the feasibility and acceptability of a smartphone app designed to provide postpartum education, screening and tracking, and positive parenting support for newly postpartum English-language speakers in Pennsylvania. This trial will also examine the preliminary effectiveness of the smartphone app for identifying symptoms and supporting positive parenting beliefs by measuring knowledge and attitude changes from pre-app use to post-app use.
- Conditions
- Postpartum
- Being tested
- Smartphone application
- Keywords
- postpartum, parenting, smartphone, mobile applications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Smartphone applicationOther
The smartphone app is designed to provide postpartum education, screening and tracking, and positive parenting support for newly postpartum English-language speakers in Pennsylvania.
| Study group | Role | What they receive |
|---|---|---|
| Postpartum support app | Experimental | All study participants will be given access to a postpartum support app. They will be asked to use this app for 8 weeks. Periodic surveys will be administered at 10 days, 4 weeks, and 8 weeks post enrollment. Baseline measurements will be collected at enrollment. Receives: Other: Smartphone application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of App
20 questions tailored from the Unified Theory of Acceptance of Use of Technology (UTAUT) asked at 3 study timepoints: 10 days, 4 weeks, and 8 weeks. 11 of the 20 questions are repeated across timepoints that assess the smartphone app (e.g., "The amount of information in [the app] is what I need" or "Overall, I like [the app]"). The remaining 9 are specific to distinct features of the app that are made available to the user at specific timepoints (e.g., "I like the way the healing check-in looks and feels"; "I like the way the [2-month] baby milestones look and feel"). Answers are measured on a 5-point Likert scale, ranging from (1)strongly disagree to (5) strongly agree (5), unless reverse-coded. Means and standard deviations will be calculated for each item, with higher responses indicating higher levels of acceptability.
Measured: Day 10, Week 4, and Week 8 of study participation
Feasibility of App Use
Feasibility will be measured using rate of engagement. Engagement will be evaluated by the number of study weeks that users uniquely access the smartphone app.
Measured: From enrollment (baseline) to the end of study participation at 8 weeks.
Secondary outcomes (2)
Knowledge - postpartum symptoms
From a list of 14 postpartum symptoms, participants will be asked to classify the symptom with the appropriate response: monitor at home, call your provider, or call 911/seek emergency care. Baseline knowledge will be measured at enrollment based on the number correct out of 14, with follow-up measurements taken at 10 days, 4 weeks, and 8 weeks.
Measured: Enrollment (baseline), day 10, week 4, and week 8 of study participation
Attitudes - positive parenting
From a list of 10 statements focused on parenting practices, participants will rate the statements from strongly disagree (1) to strongly agree (5). Example statements include, "Skin-to-skin contact improves baby health and development," "Babies need strict routines" (reverse coded), and "Infants should be fed when they show hunger cues." These responses are summed, with higher scores indicating stronger endorsement of positive parenting. These measurements are taken as a baseline measurement at enrollment, and then again at 10 days, 4 weeks, and 8 weeks.
Measured: Enrollment (baseline), day 10, week 4, and week 8 of study participation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2025
- Study start1 Dec 2025
- Primary completion29 May 2026
- Study completion29 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PostpartumStudies of the same condition, open and under way.
- More trials run by University of PittsburghThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pittsburgh
- Sponsor type
- University, hospital or other
- Collaborators
- Tuscarora Intermediate Unit 11
- Responsible party
- Principal investigator, Tamar Krishnamurti, University of Pittsburgh
- Investigators
- Tamar Krishnamurti, PhD, Principal investigator, University of Pittsburgh
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07295015
- Sponsor's protocol ID
- STUDY24110002
- Status last verified
- Dec 2025
- First submitted
- 3 Dec 2025
- Last updated
- 6 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Digital Maternal Support Tool Implementation: Research to Inform a Statewide Postpartum App Implementation Strategy
- ClinicalTrials.gov ID
- NCT07295015
- Acronym / sponsor ID
- STUDY24110002
- Conditions
- Postpartum
- Keywords
- postpartum, parenting, smartphone, mobile applications
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University of PittsburghUniversity, hospital or other
- Collaborators
- Tuscarora Intermediate Unit 11
- Study start
- 1 Dec 2025 (actual)
- Primary completion
- 29 May 2026 (actual)
- Study completion
- 29 May 2026 (actual)
- First posted
- 19 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to learn if a smartphone app designed to provide postpartum support is acceptable to new mothers in Pennsylvania. The main questions it aims to answer are:
- How easy is the app is to use?
- Does the app meet the needs of new parents?
- Is using the app associated with better understanding of critical postpartum symptoms?
- Is using the app associated with endorsement of positive parenting statements?
Participants will:
- Use a postpartum support app on their smartphones for 8 weeks
- Answer survey questions about their experience
Detailed description
The goal of this clinical trial is to evaluate the feasibility and acceptability of a smartphone app designed to provide postpartum education, screening and tracking, and positive parenting support for newly postpartum English-language speakers in Pennsylvania. This trial will also examine the preliminary effectiveness of the smartphone app for identifying symptoms and supporting positive parenting beliefs by measuring knowledge and attitude changes from pre-app use to post-app use.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Postpartum support app | Experimental | Other: Smartphone applicationAll study participants will be given access to a postpartum support app. They will be asked to use this app for 8 weeks. Periodic surveys will be administered at 10 days, 4 weeks, and 8 weeks post enrollment. Baseline measurements will be collected at enrollment. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Recently delivered one or two live births at hospital recruitment site
- 18-45 years of age
- Can participate in English
- Has smartphone access for at least two months (study duration)
Key exclusion criteria (4 listed)
- Did NOT recently deliver one or two live births at hospital recruitment site
- <18 or >45 years of age
- Cannot participate in English
- Does not have smartphone for at least two months (study duration)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Smartphone applicationThe smartphone app is designed to provide postpartum education, screening and tracking, and positive parenting support for newly postpartum English-language speakers in Pennsylvania. | Other | Postpartum support app |
Primary outcome
Acceptability of App
Time frame: Day 10, Week 4, and Week 8 of study participation
20 questions tailored from the Unified Theory of Acceptance of Use of Technology (UTAUT) asked at 3 study timepoints: 10 days, 4 weeks, and 8 weeks. 11 of the 20 questions are repeated across timepoints that assess the smartphone app (e.g., "The amount of information in [the app] is what I need" or "Overall, I like [the app]"). The remaining 9 are specific to distinct features of the app that are made available to the user at specific timepoints (e.g., "I like the way the healing check-in looks and feels"; "I like the way the [2-month] baby milestones look and feel"). Answers are measured on a 5-point Likert scale, ranging from (1)strongly disagree to (5) strongly agree (5), unless reverse-coded. Means and standard deviations will be calculated for each item, with higher responses indicating higher levels of acceptability.
Feasibility of App Use
Time frame: From enrollment (baseline) to the end of study participation at 8 weeks.
Feasibility will be measured using rate of engagement. Engagement will be evaluated by the number of study weeks that users uniquely access the smartphone app.
2 secondary outcomes
Knowledge - postpartum symptoms
Time frame: Enrollment (baseline), day 10, week 4, and week 8 of study participation
Attitudes - positive parenting
Time frame: Enrollment (baseline), day 10, week 4, and week 8 of study participation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Postpartum
Not yet recruiting
Evaluating the Healthy Families PrEP Program for Women at Risk for HIV
HIV, Pregnancy
RecruitingObservational study
Ablation Versus Non-ablation Strategies for Non-puerperal Mastitis: A Prospective Real-world Registry Study
Non-Puerperal Mastitis
Enrolling by invitation
Online-Delivered Core Stability Exercises in Postpartum Women
Postpartum, Trunk Muscle Endurance
Recruiting
The Goal is to Examine the Impact of Doula-delivered, Nurse-coordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
Doula Support, Postpartum
RecruitingPhase 4
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
Hypertensive Disorders of Pregnancy, Preeclampsia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tamar Krishnamurti, PhD principal investigator
University of Pittsburgh
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Smartphone application in people with Postpartum, run by University of Pittsburgh at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of App (time frame: Day 10, Week 4, and Week 8 of study participation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.